Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
IRVINE, Calif., July 17, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that veteran healthcare and finance executive Robert E. Hoffman has been appointed to the Board of Directors, effective immediately. Hoffman, 47, fills a current vacancy on the Board, which with his appointment is now made up of seven directors.
Help employers find you! Check out all the jobs and post your resume.
IRVINE, Calif., July 17, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that veteran healthcare and finance executive Robert E. Hoffman has been appointed to the Board of Directors, effective immediately. Hoffman, 47, fills a current vacancy on the Board, which with his appointment is now made up of seven directors.
Help employers find you! Check out all the jobs and post your resume.
